26/05/2026
A 2023 study published in the International Journal of Molecular Sciences found that CBG demonstrated broad anti-inflammatory effects in rheumatoid arthritis cell models, including reductions in inflammatory cytokines linked to joint damage and pain.
Researchers concluded that CBG “might be used as add-on therapy in RA.”
Additional 2025 preclinical research investigating CBG in rheumatoid arthritis models reported suppression of inflammatory signalling pathways associated with disease progression.
The science around non-intoxicating cannabinoids like CBG continues to expand rapidly.